Status | Study |
Recruiting |
Study Name: Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers Condition: Peptic Ulcer Date: 2015-09-14 Interventions: Drug: proton pump inhibitor (PPI) group pantoprazole |
Completed |
Study Name: Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients Condition: Peptic Ulcer Hemorrhage Date: 2015-05-25 Interventions: Drug: oral esomeprazole 20 mg twice daily |
Recruiting |
Study Name: Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer Condition: Peptic Ulcer Date: 2015-04-12 Interventions: Drug: histamine-2 receptor antagonist (famotidine) |
Recruiting |
Study Name: Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users Condition: Peptic Ulcer Date: 2014-12-19 Interventions: Drug: Placebo Drug : Placebo |
Recruiting |
Study Name: DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers Condition: Non-Bleeding Peptic Ulcers Date: 2014-10-07 Interventions: Drug: Omeprazole 2 Omeprazole |
Completed |
Study Name: Multicenter Validation on Predicting Mortality for Patients With Bleeding Peptic Ulcers Condition: Bleeding Peptic Ulcer Date: 2014-09-16 |
Completed |
Study Name: The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers Condition: Peptic Ulcer Hemorrhage Date: 2014-07-20 Interventions: Drug: esomeprazole or pantoprazole |
Completed |
Study Name: Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study Condition: Peptic Ulcer Bleeding Date: 2014-05-29 |
Completed |
Study Name: The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users Condition: Uncomplicated Peptic Ulcer Date: 2013-03-18 |
Completed |
Study Name: Risk of Uncomplicated Peptic Ulcer in the General Population Condition: Peptic Ulcer [Iowa Type (107680.0010)] Date: 2013-03-18 Interventions: Drug: Risk of symptomatic peptic ulcer Current use of drugs (ASA; NSAIDs, SSRI,PPI, H2RA) versus non-use |